CDSCO Approval & CDSCO License Guide in India 2026

From the start in 2025, clinical research organizations might qualify as CROs online through the SUGAM Portal.
For the acquisition of devices used in public health programs, new regulations calls for products that are licensed.
📞 +91 7011067811
✉️ [email protected]

#CDSCO approval, #CDSCO approvals India, #CDSCO licence, #CDSCO registration, #CDSCO regulatory approval, #CDSCO consultant,

Read more info: https://umspcs.in/blog/cdsco-approval-cdsco-license-guide-in-india-2026/

CDSCO Approval & CDSCO License Guide in India 2026

You can get expert assistance for CDSCO approvals and regulatory compliance at UMSPCS. Among their services like CDSCO License, Bis Certificate

UMSPCS
AstraZeneca Pharma India has received CDSCO approval to sell and distribute Durvalumab (Imfinzi) for an additional cancer indication, expanding treatment options for endometrial cancer patients. https://english.mathrubhumi.com/lifestyle/health/astrazeneca-cdsco-approval-durvalumab-new-cancer-indication-wbbem2rw?utm_source=dlvr.it&utm_medium=mastodon #AstraZeneca #Durvalumab #Imfinzi #CDSCO #CancerTreatment
CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews
AstraZeneca Pharma India receives CDSCO approval for Trastuzumab Deruxtecan for additional cancer indications https://english.mathrubhumi.com/news/india/astrazeneca-cancer-drug-india-approval-ojvxhabc?utm_source=dlvr.it&utm_medium=mastodon #astrazeneca #pharmaindia #cdsco #cancer

CDSCO Writes To Tamil Nadu FDA, Seeks Strictest Action on ‘Coldrif’ Manufacturer

CDSCO Writes To Tamil Nadu FDA, Seeks Strictest Action on ‘Coldrif’ Manufacturer #cdsco #tamilnadu #fda #coldrif #otvnewsenglish #otvnews --------------------------------------------------------------------------------------------------------- OdishaTV is Odisha's no 1 News Channel. OTV being the first private satellite TV channel in Odisha carries the onus of charting a course that…

https://www.odnews.in/cdsco-writes-to-tamil-nadu-fda-seeks-strictest-action-on-coldrif-manufacturer/

The Central Drugs Standard Control Organisation (CDSCO) is set to take stringent action against Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup, following reports of several child fatalities linked to the product, ANI reported, citing sources. https://english.mathrubhumi.com/news/india/cdsco-to-urge-tn-fda-to-take-strict-action-against-coldrif-syrup-manufacturer-sources-kbkaerjk?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #CoughSyrup #LatestNews #Coldrif #LatestNews